Variability in responsiveness to oral antiplatelet therapy.


Patients who have acute coronary syndromes or are undergoing percutaneous coronary intervention receive antiplatelet therapy to reduce the risk of atherothrombotic complications. Current guidelines favor the use of aspirin in combination with clopidogrel based on the results of a number of large-scale clinical trials. Aspirin alone is a relatively weak… (More)
DOI: 10.1016/j.amjcard.2008.11.020


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics